Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate entries are automatically filled from PubMed, and the page revision updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed a general government funding/status notice that previously warned about possible updates and NIH operating status. This notice did not pertain to the study details, eligibility, or results on the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:10.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Minimal layout and typography adjustments to the Study Details page with no changes to core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:39.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T06:56:28.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:35:13.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:42:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.